londhe1234

1

• Gonorrhea Therapeutics Market 
• By Gonococcal Infection Uncomplicated Gonococcal
  Infection, Gonococcal Arthritis, Gonococcal
  Meningitis, and Endocarditis Treatment
  Monotherapy and Dual Therapy Route of
  Administration Oral and Injectable Gender
  Women and Men Distribution Channel Hospital
  Pharmacies, Retail Pharmacies, Online Pharmacies,
  and Forecast 2019 - 2027

2019 Transparency Market Research, All Rights
Reserved
2
Table of Content
Sr. No. Content
Chapter1 Preface
Chapter 2 Assumptions and Research Methodology
Chapter 3 Executive Summary Global Gonorrhea Therapeutics Market 
Chapter 4 Market Overview
Chapter 5 Market Outlook
Chapter 6 Global Gonorrhea Therapeutics Market Analysis and Forecast, by Gonococcal Infection Type
Chapter 7 Global Gonorrhea Therapeutics Market Analysis and Forecast, by Treatment
Chapter 8 Global Gonorrhea Therapeutics Market Analysis and Forecast, by Route of Administration
Chapter 9 Global Gonorrhea Therapeutics Market Analysis and Forecast, by Gender
Chapter 10 Global Gonorrhea Therapeutics Market Analysis and Forecast, by Distribution Channel
Chapter 11 Global Gonorrhea Therapeutics Market Analysis and Forecast, by Region
Chapter 12 North America Gonorrhea Therapeutics Market Analysis and Forecast
Chapter 13 Europe Gonorrhea Therapeutics Market Analysis and Forecast
Chapter 14 Competition Landscape
2019 Transparency Market Research, All Rights
Reserved
3
Reports Highlights

• The global gonorrhea Therapeutics Market to Reach
  a Valuation of US 2 Bn by 2027
• and is projected to expand at a CAGR of
  5 from 2019 to 2027.
• Gonorrhea is a common bacterial sexually
  transmitted disease (STD) that can cause serious
  complications if not detected and treated.
• Gonorrhea testing identifies if the bacteria
  Neisseria gonorrhea is the cause of a person's
  infection. Screening, for diagnosing, and
  treating gonorrhea is highly important to prevent
  long-term complications and spread of the
  infection.
• Tools for gonorrhea diagnosis include microscopy,
  culture, and various nonculture methods. The
  increasing prevalence of gonorrhea and the advent
  of new diagnostic tests are expected to drive
  the growth of the gonorrhea therapeutics market.

2019 Transparency Market Research, All Rights
Reserved
4
2019 Transparency Market Research, All Rights
Reserved
5
Continue..

• The rising prevalence of the disease and
  increasing use of new diagnostic tests are key
  factors that fuel the global gonorrhea
  therapeutics market.
• Gonorrhea is a sexually transmitted infection
  caused by a bacterium, and can be transmitted
  through sexual contact. All people who are
  sexually active may be at the risk of acquiring
  gonorrhea. 
• Symptoms can include vaginal pain, painful
  urination, and an abnormal discharge from the
  vagina, urethra, or rectum. Gonorrhea tests
  include obtaining samples from the sites of
  suspected infection and testing for the presence
  of the bacteria. 
• Key players operating in the global gonorrhea
  therapeutics market include GlaxoSmithKline plc.
  Merck Co., Inc., Pfizer Inc, AstraZeneca,
  Hologic, Inc., Danaher, Abbott, Becton Dickinson
  and Company, and F. Hoffmann-La Roche Ltd.

Request Sample of Report
2019 Transparency Market Research, All Rights
Reserved
6
2019 Transparency Market Research, All Rights
Reserved
7
Contact Us
Mr. Rohit Bhisey Transparency Market
Research State Tower, 90 State Street, Suite
700, Albany, NY 12207, United States Tel
1-518-618-1030, USA - Canada Toll Free
866-552-3453 Email sales_at_transparencymarketresear
ch.com Website https//www.transparencymarketrese
arch.com Research Blog https//www.europlat.org/
2019 Transparency Market Research, All Rights
Reserved
8

• Thank You